TD Cowen analyst Bryan Bergin raised the firm’s price target on CI&T to $10 from $9 and keeps a Buy rating on the shares. The firm said its growth outperformance and upbeat tone stand out in an ...
New Analyses Related to Aficamten Expand on its Metabolism Pathways,Treatment Effect Associated with Combination Therapy with Disopyramideand ...
{"version":1,"config":{"env":{},"webpack":null,"eslint":{"ignoreDuringBuilds":false},"typescript":{"ignoreBuildErrors":false,"tsconfigPath":"tsconfig.json"},"distDir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback